Chongqing Huading Modern Biopharmaceutical

Chongqing Huading Modern Biopharmaceutical is a pharmaceutical manufacturing company based in Chongqing, China, and a wholly-owned subsidiary of Chongqing Pharscin Pharmaceutical. The company specializes in the production of active pharmaceutical ingredients (APIs) and finished dosages, with a core focus on metabolic diseases such as type 2 diabetes. Its primary products include alpha-glucosidase inhibitors like Acarbose, which are manufactured using advanced fermentation and purification technologies. The company's facilities in the Shuitu High-tech Industrial Park are GMP-certified, ensuring high standards for domestic and international supply. As a key production arm for its parent company, it plays a vital role in the large-scale commercialization of essential diabetic medications.